SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 71 filers reported holding SIERRA ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $59,000 | -11.9% | 170,912 | +42.6% | 0.01% | +50.0% |
| Q2 2019 | $67,000 | +109.4% | 119,841 | +542.8% | 0.00% | +100.0% |
| Q1 2019 | $32,000 | +39.1% | 18,645 | +35.4% | 0.00% | +100.0% |
| Q3 2018 | $23,000 | -85.3% | 13,768 | -73.9% | 0.00% | -85.7% |
| Q2 2018 | $156,000 | +108.0% | 52,694 | +45.8% | 0.01% | +75.0% |
| Q1 2018 | $75,000 | +66.7% | 36,129 | +196.5% | 0.00% | +100.0% |
| Q4 2017 | $45,000 | – | 12,186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 8,112,121 | $9,491,000 | 4.86% |
| New Leaf Venture Partners, L.L.C. | 2,744,088 | $3,211,000 | 2.26% |
| DAFNA Capital Management LLC | 265,000 | $310,000 | 0.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,495,734 | $4,090,000 | 0.22% |
| Perceptive Advisors | 3,655,186 | $4,277,000 | 0.22% |
| NEXTHERA CAPITAL LP | 400,000 | $468,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 1,662,487 | $1,945,000 | 0.13% |
| AWM Investment Company, Inc. | 500,000 | $585,000 | 0.10% |
| VHCP Management II, LLC | 130,798 | $153,000 | 0.06% |
| Orbimed Advisors | 3,703,704 | $4,333,000 | 0.04% |